PillRx only · Patch, Extended Release · Transdermal
Buprenorphine
Brands: Butrans · Buprenorphine
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 24 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$49.382
Latest avg · Jul 22, 2026
+1%
Since Dec 17, 2025
6
Active US suppliers
38%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
57K
Rx · 2026 Q1
222K
Units dispensed
+9%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Ingenus Pharmaceuticals, LLC | unknown | 5 | SUPPLYING |
| Aveva Drug Delivery Systems Inc. | unknown | 5 | SUPPLYING |
| Knoa Pharma LLC | unknown | 5 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 5 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 5 | SUPPLYING |
| LTS Therapy Systems, LLC | unknown | 1 | SUPPLYING |
| Alvogen Inc. | unknown | 4 | EXITED 2027 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 4, 2020RECALLRecall (Class II): Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured b…
Failed Stability Specifications: Below specification result for buprenorphine release rate. — Recalling firm: Teva Pharmaceuticals USA — Nationwide in the U.S. and PR